This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Metachromatic leukodystrophy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Metachromatic leukodystrophy (MLD) is a lysosomal storage disease

  • is an autosomal recessive hereditary neurodegenerative disease belonging to the group of lysosomal storage diseases (LSDs)
  • one of the most common leukodystrophies, and has a prevalence rate of 1 in 40,000-160,000 worldwide (1)
    • in some isolated populations, the incidence of MLD is much higher. For example, in the group of Habbanite (Jews) it is estimated at 1 in 75, among the Navajo Indian people at 1 in 2,500, and among the Arab groups of Israel it is estimated at 1 in 8,000
  • characterized by damage of the myelin sheath that covers most of nerve fibers of the central and peripheral nervous systems
  • disease occurs due to a deficiency of the lysosomal enzyme arylsulfatase A (ARSA) or its sphingolipid activator protein B (SapB) and it clinically manifests as progressive motor and cognitive deficiency
    • ARSA and SapB protein deficiency are caused by mutations in the ARSA and PSAP genes, respectively
    • severity of clinical course in metachromatic leukodystrophy is determined by the residual ARSA activity, depending on the type of mutation
    • MLD causes demyelination to occur, leading to impaired motor function, spastic tetraparesis, ataxia, spasms, optic atrophy, and cognitive impairment
      • however, the exact mechanisms of demyelination in MLD remain unknown (1)

Atidarsagene autotemcel is recommended, within its marketing authorisation, as an option for treating metachromatic leukodystrophy with mutations in the arylsulphatase A (ARSA) gene (2):

  • for children who have late infantile or early juvenile types, with no clinical signs or symptoms
  • for children who have the early juvenile type, with early clinical signs or symptoms, and who can still walk independently and have no cognitive decline

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.